ERBB2 and cancer: Associated with poor prognosis in ER-positive/HER2 negative breast cancer. Mitotic checkpoint gene. Overexpression is associated with cell proliferation, may be a marker for chromosomal instability, and predicts poor outcome in breast and other cancers.